View in EDS HTML Full Text PDF Full Text

Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events.

Saved in:
Bibliographic Details
Title: Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events.
Authors: Sidelnikov, Eduard (AUTHOR), Kalich, Bethany A (AUTHOR), Miglins, Margot Lisa (AUTHOR), Multani, Jasjit K (AUTHOR), Tuly, Rifat (AUTHOR), Hawkins, Kevin (AUTHOR), Baber, Usman (AUTHOR)
Source: Therapeutics & Clinical Risk Management. May2025, Vol. 21, p727-736. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 185783943
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Sidelnikov%2C+Eduard%22">Sidelnikov, Eduard</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kalich%2C+Bethany+A%22">Kalich, Bethany A</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Miglins%2C+Margot+Lisa%22">Miglins, Margot Lisa</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Multani%2C+Jasjit+K%22">Multani, Jasjit K</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Tuly%2C+Rifat%22">Tuly, Rifat</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hawkins%2C+Kevin%22">Hawkins, Kevin</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Baber%2C+Usman%22">Baber, Usman</searchLink> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Therapeutics+%26+Clinical+Risk+Management%22">Therapeutics & Clinical Risk Management</searchLink>. May2025, Vol. 21, p727-736. 10p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=185783943
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/TCRM.S512708
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 10
        StartPage: 727
    Titles:
      – TitleFull: Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sidelnikov, Eduard
      – PersonEntity:
          Name:
            NameFull: Kalich, Bethany A
      – PersonEntity:
          Name:
            NameFull: Miglins, Margot Lisa
      – PersonEntity:
          Name:
            NameFull: Multani, Jasjit K
      – PersonEntity:
          Name:
            NameFull: Tuly, Rifat
      – PersonEntity:
          Name:
            NameFull: Hawkins, Kevin
      – PersonEntity:
          Name:
            NameFull: Baber, Usman
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: May2025
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 11766336
          Numbering:
            – Type: volume
              Value: 21
          Titles:
            – TitleFull: Therapeutics & Clinical Risk Management
              Type: main
ResultId 1